Skip to main content
SpringerLink
Log in

Kontrastmittel in der Radiologie

Aktuelle Zulassungen, Empfehlungen und Sicherheitshinweise

Contrast agents in radiology

Current agents approved, recommendations, and safety aspects

  • CME Zertifizierte Fortbildung
  • Published:
Der Radiologe Aims and scope Submit manuscript

An Erratum to this article was published on 18 May 2013

Zusammenfassung

Im vorliegenden Beitrag werden aktuelle Zulassungen und Indikationen zur Anwendung von Kontrastmitteln besprochen. Dies beinhaltet jodhaltige Kontrastmittel, Magnetresonanztomographiekontrastmittel und Ultraschallkontrastmittel. Unerwünschte allergische und renale Wirkungen werden diskutiert. Die Datenlage zur Medikation von Metformin bei Kontrastmittelgabe wird analysiert. Das Krankheitsbild der nephrogenen systemischen Fibrose (NSF) wird erläutert und die damit verbundene Datenlage bezüglich der verschiedenen Magnetresonanztomographiekontrastmittel wird dargestellt. Die aktuellen Änderungen der ESUR-Leitlinien (ESUR: „European Society of Urogenital Radiology“) werden ebenfalls präsentiert.

Abstract

The manuscript summarizes current approved contrast media and their indications. Contrast agents that are discussed include iodinated contrast agents, magnetic resonance (MR) contrast agents, and ultrasound contrast agents. Allergic and non-allergic renal adverse events are described. The clinical issue of metformin and the administration of contrast agents are updated. Nephrogenic systemic fibrosis (NSF) is discussed and safety issues of available MR contrast agents are analyzed. The most recent changes in European Society of Urogenital Radiology (ESUR) guidelines are also presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Thomsen HS, Webb JA (Hrsg) (2012) ESUR guidelines on contrast media, Version 8.0. European Society of Urogenital Radiology, Wien. http://www.esur.org/guidelines/. Zugegriffen: 16.12.2012

  2. Knopp MV, Balzer T, Esser M et al (2006) Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use. Invest Radiol 41(6):491–499

    Article  PubMed  Google Scholar 

  3. Jung JW, Kang HR, Kim MH et al (2012) Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology 264(2):414–422

    Article  PubMed  Google Scholar 

  4. Hunt CH, Hartman RP, Hesley GK (2009) Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses. AJR Am J Roentgenol 193(4):1124–1127

    Article  PubMed  Google Scholar 

  5. Golder W ((2012) Kombinierter zeitnaher Einsatz jod- und gadoliniumhaltiger Kontrastmittel in der diagnostischen und interventionellen Radiologie. Ein bisher vernachlässigtes Kapitel der radiologischen Praxis. Radiologe 52:167–172

    Article  PubMed  CAS  Google Scholar 

  6. Kubik-Huch RA, Gottstein-Aalame NM, Frenzel T et al (2000) Gadopentetate dimeglumine excretion into human breast milk during lactation. Radiology 216(2):555–558

    PubMed  CAS  Google Scholar 

  7. Claudon M, Cosgrove D, Albrecht T et al (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall Med 29(1):28–44

    Article  PubMed  CAS  Google Scholar 

  8. Bellin MF, Stacul F, Webb JA et al (2011) Late adverse reactions to intravascular iodine based contrast media: an update. Eur Radiol 21(11):2305–2310

    Article  PubMed  Google Scholar 

  9. Moan R (2012) ESUR updates guidelines to prevent NSF. AuntMinnieEurope, http://www.auntminnieeurope.com/index.aspx?sec=sup&sub=mri&pag=dis&ItemID=607058. Zugegriffen: 16.12.2012

  10. Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9(8):1602–1613

    Article  PubMed  CAS  Google Scholar 

  11. Stacul F, Molen AJ van der, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21(12):2527–2541

    Article  PubMed  Google Scholar 

  12. Girardi M, Kay J, Elston DM et al (2011) Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol 65(6):1095–1106.e7

    Article  PubMed  Google Scholar 

  13. Vosshenrich R, Reimer P (2009) Nephrogenic systemic fibrosis. Vasa 38(1):31–38

    Article  PubMed  CAS  Google Scholar 

  14. Bennett CL, Qureshi ZP, Sartor AO et al (2012) Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. Clin Kidney J 5(1):82–88

    Article  PubMed  CAS  Google Scholar 

  15. Thomsen HS (2007) ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol 17(10):2692–2696

    Article  PubMed  Google Scholar 

  16. Thomsen HS, Morcos SK, Almen T et al (2013) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 23(2):307–318

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Institut für diagnostische und interventionelle Radiologie, Klinikum Karlsruhe, Moltkestraße 90, 79133, Karlsruhe, Deutschland

    P. Reimer

  2. Praxis für moderne Schnittbild Diagnostik, Göttingen, Deutschland

    R. Vosshenrich

Authors
  1. P. Reimer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Vosshenrich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Reimer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reimer, P., Vosshenrich, R. Kontrastmittel in der Radiologie . Radiologe 53, 153–164 (2013). https://doi.org/10.1007/s00117-012-2429-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00117-012-2429-6

Schlüsselwörter

Keywords

Search

Navigation